Bio-Techne Corp. buy UBS Group AG
Start price
07.12.23
/
50%
€62.50
Target price
07.12.24
€74.12
Performance (%)
14.40%
End price
08.12.24
€71.50
Summary
This prediction ended on 08.12.24 with a price of €71.50. The prediction had a final performance of 14.40%. UBS_Group_AG has a follow-up prediction for Bio-Techne Corp. where he still thinks Bio-Techne Corp. is a Buy. A total of €0.30 was paid as dividends for this prediction. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bio-Techne Corp. | -0.983% | -0.983% | 23.683% |
| iShares Core DAX® | 2,59 % | 2,69 % | 6,41 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % | 20,65 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % | 46,17 % |
| iShares S&P 500 | -0,37 % | -0,83 % | 18,02 % |
Comments by UBS_Group_AG for this prediction
In the thread Bio-Techne Corp. diskutieren
Bio-Techne Co. (NASDAQ: TECH) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $80.00 price target on the stock.
Ratings data for TECH provided by MarketBeat
In the thread Trading Bio-Techne Corp.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten